Funding from The Michael J. Fox Foundation

by muelo | Feb 24, 2021

Funding from The Michael J. Fox FoundationFeb. 24, 2021 PDF-Download h PDF Download Press Release Priavoid and Forschungszentrum Jülich receive funding from The Michael J. Fox Foundation Düsseldorf, Germany, February 24th, 2021: A collaboration project of...

Priavoid closes financing round

by Gunther Kauselmann | Feb 12, 2021

Priavoid closes financing roundFebruary 12th, 2021 PDF-Download h PDF Download EN Press Release Priavoid closes financing round Düsseldorf, Germany, February 12th, 2021: Priavoid GmbH closes a Series A financing round in the amount of EUR 7 million. The...

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

by Gunther Kauselmann | Feb 11, 2021

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-TherapieFeb. 4, 2021 PDF-Download h PDF Download Press Release Sprunginnovationsprojektgeht neue Wege in der Alzheimer-Therapie Leipzig, am 4. Februar 2021 Die Bundesagentur für Sprunginnovationen SPRIND...

Alzheimer´s Research: Important Milestone for PRI-002

by muelo | Feb 4, 2021

Important Milestone for PRI-002Feb. 4, 2021 PDF-Download h PDF Download Press Release Alzheimer´s Research: Important Milestone for PRI-002 Düsseldorf, Germany, Feb. 4, 2021 – The innovative drug candidate PRI-002 against Alzheimer’s dementia will...

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

by muelo | Dec 9, 2020

Nobel Prize winner Stanley Prusiner joins Priavoid's supervisory boardDecember 9th, 2020 PDF-Download h PDF Download Press Release Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board Düsseldorf/San Francisco, 9 December 2020 – Stanley...